Lv2
120 积分 2023-08-18 加入
Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity
4小时前
待确认
Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders
3个月前
已关闭
Transplant in AML: just follow the NPM1 guide!
6个月前
已完结
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
6个月前
已完结
High-risk Multiple Myeloma: Definition and Management
1年前
已完结
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
1年前
已完结
Zanubrutinib, lenalidomide, and rituximab (ZR2 regimen) for HIV-associated diffuse large B-cell lymphoma: a real-world analysis from China
1年前
已完结
Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis
1年前
已完结
皖公网安备34019202002308
